Annual Healthcare Industry Outlook
Meet Our Speakers
Sarah Alwardt
As president of Avalere, Sarah Alwardt leads the firm’s consulting, sales, and operational functions. Sarah previously led Avalere’s Evidence & Strategy practice, helping clients understand barriers to care in key markets; generating evidence about patients’ experiences and priorities; and assessing how health inequities impact clients’ businesses. Before joining Avalere, Sarah launched and grew Ontada, McKesson’s oncology research business, and spent 10 years at Humana.
Adapting to Cost Pressures and Reimbursement Changes
Maddi Davidson
PrincipalLauren Makhoul (Cricchi)
Associate PrincipalMilena Sullivan
Managing DirectorNavigating the Uncertainty of Scientific Progress and Policy Change
Nicole Betor
Consultant IIAshley Flint
PrincipalMark Gooding
Managing DirectorMichael Lutz
Senior ConsultantDeveloping an Integrated Business Strategy
Nancy El Hoyek
Associate PrincipalRobin Duddy-Tenbrunsel
PrincipalEric Levine
Associate PrincipalBrigit Kyei-Baffour
PrincipalView Our 2024 Annual Outlook
Accelerate your organization’s impact in 2024 as you navigate the Inflation Reduction Act’s seismic shifts to healthcare markets, prepare for the increasing importance of evidence-based decision making, and continue to focus on how industry trends are affecting patients.
Accelerate Your Impact in 2024
Sarah Alwardt, President, moderated a live discussion with Avalere experts regarding the top healthcare issues coming year in 2024. The conversation and report offered actionable insights on:
- Adapting to the IRA’s landmark policies by changing your assumptions about the Part D and Medicare Advantage market
- Enhancing your organization’s impact on access, utilization, and outcomes with strategic use of data and analytics
- Maintaining a patient-centric perspective by understanding how these trends impact patients